立華股份(300761.SZ):兩名董事、高管擬合計減持不超150萬股
格隆匯 11 月 6日丨立華股份(300761.SZ)公佈,公司於近日收到董事兼副總裁魏鳳鳴、副總裁張康寧發來的《股份減持計劃告知函》。
公司董事、副總裁魏鳳鳴直接持有公司股份870.3萬股(佔公司總股本2.15%),計劃自公告披露之日起15個交易日後的六個月內(窗口期不減持)以集中競價或大宗交易方式合計減持公司股份不超過100萬股(佔公司總股本比例0.25%)。
公司副總裁張康寧直接持有公司股份297.5萬股(佔公司總股本0.74%),計劃自公告披露之日起15個交易日後的六個月內(窗口期不減持)以集中競價或大宗交易方式合計減持公司股份不超過50萬股(佔公司總股本比例0.12%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.